Title Summary Introduction Objectives Methodology Theoretical Framework Biotechnology

1

Title

Summary

IntroductionObjectives

Methodology

Theoretical Framework

BiotechnologyInnovation

System

Preliminaryconclusions

II BRICS WORKSHOP

BIOTECHNOLOGY INNOVATION SYSTEM IN BRAZIL: AN EXPLORATORY STUDY

Valéria Judice e Conceição Vedovello

Rio de Janeiro, 26 de abril de 2007

2

Title

Introduction

Objectives

Methodology



System


INTRODUCTION

Research question: How are evolving knowledge flows, interactive learning, entrepreneurial and innovation action within Brazilian biotech?

Reviews of biotechnology evolution - Last 30 years

Knowledge-based industry, multidisciplinary

Different areas: health, agriculture, food processing, environment, new materials , new sources of energy

Brazil:

State of the art scientific developments: genomics, proteomics, pharmacogenomics

Industry – around 300 companies (Biominas / MCT, 2001)

3

Title

Introduction

Objectives

Methodology



System


OBJECTIVES

. .

General:

to establish theoretical and empirical elements to analyze biotechnology developments in Brazil within the innovation systems (IS) framework

Innovation system is understood:- As a focusing device to contextualize knowledge creation and diffusion processes

- As policy and development instrument.

4

Title

Introduction

Objectives

Methodology



System


SPECIFIC OBJECTIVES

1) to focus on Brazilian biotechnology IS and explore three sets of elements: - knowledge and technologies, - actors and networks - institutional (policy) aspects;

2) to map the main concentration and irradiation areas of biotechnology development in Brazil (critical geographical areas);

3) to offer common bases to comparisons of biotechnology IS within the BRICS group.

5

Title

Introduction

Objectives

Methodology



System


METODOLOGY - DEFINITIONS

Terminology Biotechnology refers to a broad and complex set of

enabling technologies which have in common the use of biological cells or molecules applied in the production of products and services for the development related to life sciences, biology, chemistry, medicine, agriculture and computation sciences (bioinformatics), among others. The bioindustry has diverse applications

Scope Exploratory study – empirical research is focused on the

systemic elements in three states where the strongest and most impacting biotechnology developments have taken place in Brazil: São Paulo; Minas Gerais and Rio de Janeiro

6

Title

Introduction

Objectives

Methodology



System


METHODOLOGY

Literature review, secondary data collected

Primary data collected:

questionnaires to 50 Brazilian companies (in 2001) to 48 companies (2004)

in-depth interviewing 10 company directors, CEOs and managers; case studies preparation (2005,2006)

interviews with scientists and policy makers Brasília, Rio de Janeiro, Belo Horizonte and São Paulo (2006, 2007)

7

Title

Introduction

Objectives

Methodology



System


THEORETICAL FRAMEWORK

Biotechnology innovation systemsperspectives: national, regional, local, technological, sectoral.

National approach:National and sub-national approaches of biotechnology are the most frequent in the literature. Geographical basis for contextualizing technological and sectoral aspects.

Country specific factors in the development of the biotechnology industry

Authors: Senker and van Zwanenberg, 2000, 2001; Mehra, 2001, Bartholomew, 1997, Chaturvedi, 2003, March, 2003; Kaiser and Prange, 2004; Gittelman, 2006; Mets, 2006; Wu, 2006; Marques and Gonçalves Neto, 2007.

8

Title

Introduction

Objectives

Methodology



System



Sub-national (regional) approach:

Addresses the problem of variety within national borders; analyze sectors, clusters interaction with the regional governance and innovation support infrastructures

Overlapping of regional innovation systems and clustering processes [1] - extensive publications on biotechnology cluster and geographical concentration.

Authors: Prevezer, 1997; Audretsch, 2001; Porter, 2001; Cooke, 2001a, 2003, 2004a; 2004b; Cooke et al, 1997: Koput; Bowie; Smith-Doerr, 2002; Casper; Karamanos, 2003; Feldman; Francis, 2003; Kaiser, 2003; Niosi; Bas, 2003; Kaufmann; Schwartz; Frenkel; Shefer, 2003; De Vol; Wong; Ki; Bedroussian; Koepp, 2004; Nelsen, 2005.

[1] Local Productive Arrangements, LPA in Brazil

9

Title

Introduction

Objectives

Methodology



System



The sectoral approachDeparts from geographic boundaries and defines the unit of analysis by associating interdependent organizations which operate the same product market, across nations or regions. (Malerba, 2002, 2005)

The technological approachPrivileges the composition of technological competences underpinning innovation across sectors. (Carlsson, 2002)

10

Title

Introduction

Objectives

Methodology



System



In this study: the basis for definition of the biotechnology innovation system

incorporates technological and sectoral innovation systems perspectives

Supplementing the technological perspective with the sectoral perspective makes it possible to subdivide the biotechnological innovation system into sectoral sub-systems (Carlsson and Stankiewics, 2002; Malerba 2002, 2004, 2005).

11

Title

Introduction

Objectives

Methodology



System


BIOTECHNOLOGY INNOVATION SYSTEM

Technologies:- Maturity / emergent- Composition (heteorogeneous/ homogeneous)- Localization (local, global)

Systems:Levels of analysis Technology and knowledgeProducts Technology competences

Boundary delineationWhat is the technology /knowledge field?Boundaries change over timeActor belongs to the system?

Performance Complexities of assessment Emergent systems

System integrationKnowledge flows and networksDiffusion of knowledge, interaction and learning

Figure 1: Biotechnology technological system of innovation

12

Title

Introduction

Objectives

Methodology



System



BiotechnologyKnowledge base

Public Sector Healthcare

Pharma

Agriculture Food

Energy

Chemistry

Technological:

Regimes

Opportunities

Apropriability

Cumulativeness

System integrationKnowledge flows and networksDiffusion of knowledge, interaction and learning

Figure 2: Biotechnology sectoral system of innovation (and sub-systems)

13

Title

Introduction

Objectives

Methodology



System



Figure 3: Key dimensions of Biotechnology Innovation Systems

Companies

Scientific research

Government

Venture capital

Public and private finance and investment

Institutional arrangementsPolicy making

Normative Rules of governance

(regulatory framework: intellectual property )

Cognitive, cultural

Actors and networks Institutional aspects

Exploitation of basic science ( training of HR

and learning)

Integration of heterogeneous knowledge

Exploration of markets potentials and reality

Knowledge and technologies

System integration

knowledge flows and networks

Diffusion of knowledge, interaction, learning

14

Title

Introduction

Objectives

Methodology



System



1. KNOWLEDGE AND TECHNOLOGIES

Exploitation of basic science – knowledge diffusion, learning , training HR

- Evolution of biotechnology research in Brazil from 2002-2004 (CNPq database)

- Comparative data on:Indexed paper biotechnology publication - 1991-2002BRICS (Brazil, India, China, South Africa) and other

(South Korea,Cuba, Egypt)

Biomedical USPTO patents - 1990-2003BRICS (Brazil, India, China, South Africa) and other

(South Korea, Cuba, Egypt)

15

Title

Introduction

Objectives

Methodology



System



Brazilian Database ( CNPq) – RESEARCH AREAS1

1.Biotecnology

2.Genomics

3.Proteomics

4.Pharmaceuticals

5.Pharmacogenomics

6.Pharmacogenetics

7.Biopharmaceuticals

8.Vacines

9.Molecular diagnostics

10.Plant genetics

11.Biodiversity

12.Biorremediation

13.Animal genetics

14.Imunnology

15.Biomaterials

16.Toxinology

17.Recombinant vacines

18.Stem cells

19.Biodiesel

International publication biotechnology

Patents and product registration biotechnology

Source: CNPq Research Groups Database, 2002 e 2004.

USPTO biomedical patents (1990 to 2003):

South Korea (337) India (178)China (98) Brazil (44) Cuba (29)

South Africa (29) Egypt (10)

16

Title

Introduction

Objectives

Methodology



System



2. ACTORS AND NETWORKS

40 to 60% of scientific research; 81% of companies: SP, MG and RJ

São Paulo - Knowledge leadership and the pervasiveness of the genomic network model - the ONSA organization process

Minas Gerais – the opportunity nexus, the anchor company and a biotechnology local productive arrangement (LPA) - Biobrás case

Rio de Janeiro - Constructed advantages of public goods – Oswaldo Cruz Foundation, UFRJ, Bio-Rio

17

Title

Introduction

Objectives

Methodology



System



3. INSTITUTIONAL ASPECTS

Strengthening the interaction among actors

Restrictions to consolidation of innovation systems in developing economies

(a) lack of comprehension of aspects that influence or difficult production, dissemination, utilization of information, knowledge and technology within entrepreneurial activities

(b) when obstacles are identified: lack of capacity for overcoming them

(c) lack of national policy design driven to development promotion that require and stimulate innovation in terms of industrial policy.

18

Title

Summary


Methodology



System



BRAZILIAN INNOVATION SYSTEM IN BIOTECHNOLOGY

Complexity and sophistication of methods, the employment of multidisciplinary approaches, and high costs involved in financing research.

Differentiated management is required whether biotech is to be made competitive:

Appropriate environment based on strong basic and technological research,

Incentives to the establishment of “start up” enterprises, expertise to transform knowledge into products, services and processes.

Needs of legal framework in order to deal with intellectual property, standardization, control and quality certification, biosafety and bioethics.

19

Title

Summary


Methodology



System



BRAZILIAN INNOVATION SYSTEM IN BIOTECHNOLOGY

Institutional building up and financial support

Decade of 1970 - training of HR; support to scientific and technological institutions, creation of Cenargen

Decades of 1980-1990 - ABRABI, PRONAB; Program on Endemic Diseases (PIDE); Program on Genetics (PIGE); PADCT; RHAE; CBAB; CTNBio ; Bio-Rio; Biominas; Center for Biotechnology-RS, BIOAGRO, TECPAR, (Center for Molecular Biology of Paraná State);

From late 1990’s onwards - Pluriannual Program of the Federal Government (PPA), National Program of Biotechnology and Genetic Resources (Genomic Program);Sectoral Funds for supporting S,T&I , Competitiveness Forum of Biotechnology.

2006-2007 Industrial, Technological and Trade Foreign Policy (PITCE); Biotechnology National Policy – Biotechnology Policy: Protection and Development (MCT and MDIC).

20

Title

Introduction

Objectives

Methodology



System


PRELIMINARY CONCLUSIONS

1. Study is exploratory. It was aimed at establishing theoretical and empirical bases to analyze biotechnology developments in Brazil using the innovation systems (IS) framework.

2. The study was also oriented to provide comparable IS information within the BRICS countries group.

3. Substantial human resources, research and educational infrastructure have been built up in Brazil. However, biotechnology research is concentrated in Southeast, particularly in the states of São Paulo, Minas Gerais and Rio de Janeiro. Data collected on research groups in the country (CNPq database) showed that the Southeast region is responsible for no less than 40% of biotechnology research to 60%

21

Title

Introduction

Objectives

Methodology



System



3. The organizational patterns of biotechnology industry are established in localized agglomeration areas (clusters and LPAs). About 81% of the companies are in SP, MG and RJ,

4. Collaborative arrangements and alliances involving five main actors: universities; biotech companies; pharmaceutical; government (policy, regulatory aspects), and finance (vc, public and private funding).

4. Small to medium-sized biotechnology-based enterprises, foreign and national pharmaceutical firms are currently in operation in the country.

5. Expanding the system’s capacities in innovation, sustainability and competitiveness in the future are challenges that require a strategic effort by industry, universities, R&D&I, and adequate supporting policy and governmental action in regulatory and financial fronts, as well as other relevant institutional and promotion schemes.

22

Title

Introduction

Objectives

Methodology



System



6. Main challenges involve: continuity of S,T&I policies and programs, investments; improvement of links among public and private actors; improvement of expertise integration; convergence of regulations derived from different Brazilian surveillance agencies and institutions; adjustments of legal framework - international /Brazilian; strengthening of entrepreneurial culture; consistent approach to ethical issues biotechnology.implementing a reasonable approach to biotechnology issues: more technical than political and ideological contents.

Documents

Title Summary Introduction Objectives Methodology Theoretical Framework Biotechnology